BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 26536209)

  • 1. Immediate postpartum provision of long-acting reversible contraception.
    Goldthwaite LM; Shaw KA
    Curr Opin Obstet Gynecol; 2015 Dec; 27(6):460-4. PubMed ID: 26536209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate postpartum intrauterine device and implant program outcomes: a prospective analysis.
    Eggebroten JL; Sanders JN; Turok DK
    Am J Obstet Gynecol; 2017 Jul; 217(1):51.e1-51.e7. PubMed ID: 28342716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.
    Sothornwit J; Kaewrudee S; Lumbiganon P; Pattanittum P; Averbach SH
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD011913. PubMed ID: 36302159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of frameless anchored IUD for immediate intracesarean insertion.
    Wildemeersch D; Goldstuck ND; Hasskamp T
    Dev Period Med; 2016; 20(1):7-15. PubMed ID: 27416620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices.
    Cohen R; Sheeder J; Arango N; Teal SB; Tocce K
    Contraception; 2016 Feb; 93(2):178-83. PubMed ID: 26475368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals.
    Wu M; Eisenberg R; Negassa A; Levi E
    Contraception; 2020 Dec; 102(6):409-413. PubMed ID: 32918870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum options: matching the method to individual needs.
    Townsend S
    Netw Res Triangle Park N C; 1990 Aug; 11(3):12-5. PubMed ID: 12342904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IUD insertions following cesarean deliveries examined.
    Netw Res Triangle Park N C; 1984; 5(2):4-6. PubMed ID: 12265941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Society for Maternal-Fetal Medicine (SMFM) Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications.
    ; Vricella LK; Gawron LM; Louis JM
    Am J Obstet Gynecol; 2019 May; 220(5):B2-B12. PubMed ID: 30738885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Immediate Postpartum Long-Acting Reversible Contraception Before and After a State Policy Mandated Inpatient Access.
    Brant AR; Kollikonda S; Yao M; Mei L; Emery J
    Obstet Gynecol; 2021 Nov; 138(5):732-737. PubMed ID: 34619694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient acceptability, continuation and complication rates with immediate postpartum levonorgestrel intrauterine device insertion at caesarean section and vaginal birth.
    Wojcik N; Watkins L; Nugent R
    Aust N Z J Obstet Gynaecol; 2022 Oct; 62(5):773-778. PubMed ID: 35451065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine device developments.
    Netw Res Triangle Park N C; 1984; 5(4):4-6. PubMed ID: 12313225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices.
    Whitaker AK; Chen BA
    Contraception; 2018 Jan; 97(1):2-13. PubMed ID: 28987293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease.
    Sinkey RG; Blanchard CT; Maier J; Novara A; Mazzoni SE; Goepfert AR; Boozer M; Rajapreyar I; Cribbs M; Szychowski JM; Tita ATN
    Contraception; 2022 Jan; 105():55-60. PubMed ID: 34529951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis.
    Averbach SH; Ermias Y; Jeng G; Curtis KM; Whiteman MK; Berry-Bibee E; Jamieson DJ; Marchbanks PA; Tepper NK; Jatlaoui TC
    Am J Obstet Gynecol; 2020 Aug; 223(2):177-188. PubMed ID: 32142826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Provision of immediate postpartum intrauterine contraception after vaginal birth within a public maternity setting: Health services research evaluation.
    Cooper M; McGeechan K; Glasier A; Coutts S; McGuire F; Harden J; Boydell N; Cameron ST
    Acta Obstet Gynecol Scand; 2020 May; 99(5):598-607. PubMed ID: 31837002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.